Prof Martin Brutsche
Chefarzt Pneumologie und interdisziplinäres Schlafzentrum
Chefarzt/Chefärztin
Pneumologie und Schlafmedizin · Dept. I
Accelerometer- versus questionnaire-based assessment of physical activity and their changes over time in patients with COPD
Sievi N, Brack T, Brutsche M, Frey M, Irani S, Leuppi J, Thurnheer R, Kohler M, Clarenbach C. Accelerometer- versus questionnaire-based assessment of physical activity and their changes over time in patients with COPD. Int J Chron Obstruct Pulmon Dis 2017; 12:1113-1118.
10.04.2017Accelerometer- versus questionnaire-based assessment of physical activity and their changes over time in patients with COPD
10.04.2017Int J Chron Obstruct Pulmon Dis 2017; 12:1113-1118
Sievi Noriane A, Brack Thomas, Brutsche Martin, Frey Martin, Irani Sarosh, Leuppi Jörg D, Thurnheer Robert, Kohler Malcolm, Clarenbach Christian F
24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling
Baty F, Jörger M, Früh M, Klingbiel D, Zappa F, Brutsche M. 24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling. J Transl Med 2017; 15:66.
30.03.201724h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profiling
30.03.2017J Transl Med 2017; 15:66
Baty Florent, Jörger Markus, Früh Martin, Klingbiel Dirk, Zappa Francesco, Brutsche Martin
Determinants of annual change in physical activity in COPD
Clarenbach C, Thurnheer R, Leuppi J, Irani S, Frey M, Brutsche M, Brack T, Haile S, Sievi N, Kohler M. Determinants of annual change in physical activity in COPD. Respirology 2017; 22:1133-1139.
30.03.2017Determinants of annual change in physical activity in COPD
30.03.2017Respirology 2017; 22:1133-1139
Clarenbach Christian F, Thurnheer Robert, Leuppi Jörg D, Irani Sarosh, Frey Martin, Brutsche Martin, Brack Thomas, Haile Sarah R, Sievi Noriane A, Kohler Malcolm
Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment
Funke-Chambour M, Geiser T, Tamm M, Soccal P, Nicod L, Kleiner-Finger R, Hostettler K, Clarenbach C, Brutsche M, Bridevaux P, Boehler A, Benden C, Barazzone-Argiroffo C, Adler D, Azzola A, Lazor R. Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment. Respiration 2017; 93:363-378.
25.03.2017Idiopathic Pulmonary Fibrosis in Switzerland: Diagnosis and Treatment
25.03.2017Respiration 2017; 93:363-378
Funke-Chambour Manuela, Geiser Thomas, Tamm Michael, Soccal Paola M, Nicod Laurent P, Kleiner-Finger Rebekka, Hostettler Katrin, Clarenbach Christian F, Brutsche Martin, Bridevaux Pierre-Olivier, Boehler Annette, Benden Christian, Barazzone-Argiroffo Constance, Adler Dan, Azzola Andrea, Lazor Romain
Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
Feigelman R, Kahlert C, Baty F, Rassouli F, Kleiner R, Kohler P, Brutsche M, Von Mering C. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details. Microbiome 2017; 5:20.
10.02.2017Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
10.02.2017Microbiome 2017; 5:20
Feigelman Rounak, Kahlert Christian, Baty Florent, Rassouli Frank, Kleiner Rebekka L, Kohler Philipp, Brutsche Martin, Von Mering Christian
Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study
Salomon J, Clemens A, Kostikas K, Wild C, Geiser T, Schmidt U, Fitting J, Sigrist T, Azzola A, Turk A, Frey J, Domenighetti G, Stolz D, Brutsche M. Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study. Respir Res 2017; 18:13.
11.01.2017Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD-a randomised controlled study
11.01.2017Respir Res 2017; 18:13
Salomon Joerg, Clemens Andreas, Kostikas Konstantinos, Wild Corinne, Geiser Thomas, Schmidt Ulrich, Fitting Jean-William, Sigrist Thomas, Azzola Andrea, Turk Alexander J, Frey Jean-Georges, Domenighetti Guido, Stolz Daiana, Brutsche Martin
Erratum to: NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Horvath C, Brutsche M, Schoch O, Schillig B, Baty F, vonOw D, Rüdiger J. Erratum to: NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2017; 12:1339.
01.01.2017Erratum to: NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
01.01.2017Intern Emerg Med 2017; 12:1339
Horvath Christian Michael, Brutsche Martin, Schoch Otto, Schillig Bernarde, Baty Florent, vonOw Dieter, Rüdiger Jochen Julius
Oxygen Uptake Recovery Kinetics after the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease
Baty F, van Gestel A, Kern L, Brutsche M. Oxygen Uptake Recovery Kinetics after the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease. Respiration 2016; 92:371-379.
09.11.2016Oxygen Uptake Recovery Kinetics after the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease
09.11.2016Respiration 2016; 92:371-379
Baty Florent, van Gestel Arnoldus J R, Kern Lukas, Brutsche Martin
Transcutaneous versus blood carbon dioxide monitoring during acute noninvasive ventilation in the emergency department - a retrospective analysis
Horvath C, Brutsche M, Baty F, Rüdiger J. Transcutaneous versus blood carbon dioxide monitoring during acute noninvasive ventilation in the emergency department - a retrospective analysis. Swiss Med Wkly 2016; 146:w14373.
26.10.2016Transcutaneous versus blood carbon dioxide monitoring during acute noninvasive ventilation in the emergency department - a retrospective analysis
26.10.2016Swiss Med Wkly 2016; 146:w14373
Horvath Christian Michael, Brutsche Martin, Baty Florent, Rüdiger Jochen
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Horvath C, Brutsche M, Schoch O, Schillig B, Baty F, vonOw D, Rüdiger J. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016
Horvath Christian Michael, Brutsche Martin, Schoch Otto, Schillig Bernarde, Baty Florent, vonOw Dieter, Rüdiger Jochen
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Brutsche M. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016
Brutsche Martin
NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
Brutsche M. NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours. Intern Emerg Med 2016
08.10.2016NIV by an interdisciplinary respiratory care team in severe respiratory failure in the emergency department limited to day time hours
08.10.2016Intern Emerg Med 2016
Brutsche Martin
Telehealthcare for Chronic Obstructive Pulmonary Disease in Switzerland Is Feasible and Appreciated by Patients
Rassouli F, Pfister M, Widmer S, Baty F, Burger B, Brutsche M. Telehealthcare for Chronic Obstructive Pulmonary Disease in Switzerland Is Feasible and Appreciated by Patients. Respiration 2016; 92:107-13.
24.08.2016Telehealthcare for Chronic Obstructive Pulmonary Disease in Switzerland Is Feasible and Appreciated by Patients
24.08.2016Respiration 2016; 92:107-13
Rassouli Frank, Pfister Maurus, Widmer Sandra, Baty Florent, Burger Barbara, Brutsche Martin
Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study
Neumair P, Cerny T, Krähenbühl S, Baty F, Brutsche M, Früh M, Hitz F, Ess S, Dutly A, Warschkow R, Joos L, Jörger M. Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. Lung Cancer 2016; 100:38-44.
28.07.2016Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study
28.07.2016Lung Cancer 2016; 100:38-44
Neumair P, Cerny Thomas, Krähenbühl S, Baty Florent, Brutsche Martin, Früh Martin, Hitz Felicitas, Ess S, Dutly A, Warschkow Rene, Joos L, Jörger Markus
Modeling the oxygen uptake kinetics during exercise testing of patients with chronic obstructive pulmonary diseases using nonlinear mixed models
Baty F, Ritz C, van Gestel A, Brutsche M, Gerhard D. Modeling the oxygen uptake kinetics during exercise testing of patients with chronic obstructive pulmonary diseases using nonlinear mixed models. BMC Med Res Methodol 2016; 16:66.
01.06.2016Modeling the oxygen uptake kinetics during exercise testing of patients with chronic obstructive pulmonary diseases using nonlinear mixed models
01.06.2016BMC Med Res Methodol 2016; 16:66
Baty Florent, Ritz Christian, van Gestel Arnoldus, Brutsche Martin, Gerhard Daniel
Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment
Cernomaz A, Brutsche M, Zonda R, Peter S, Baty F, Marinca M, Grigoriu C, Pavel I, Macovei I, Grigoriu B. Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment. BMC Pulm Med 2016; 16:88.
23.05.2016Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment
23.05.2016BMC Pulm Med 2016; 16:88
Cernomaz Andrei-Tudor, Brutsche Martin, Zonda Radu, Peter Simona, Baty Florent, Marinca Mihai, Grigoriu Carmen, Pavel Ionut, Macovei Ina Iuliana, Grigoriu Bogdan- Dragos
Handheld single photon emission computed tomography (handheld SPECT) navigated video-assisted thoracoscopic surgery of computer tomography-guided radioactively marked pulmonary lesions
Müller J, Putora P, Schneider T, Zeisel C, Brutsche M, Bartz-Batliner M, Markus A, Kick J. Handheld single photon emission computed tomography (handheld SPECT) navigated video-assisted thoracoscopic surgery of computer tomography-guided radioactively marked pulmonary lesions. Interact Cardiovasc Thorac Surg 2016; 23:345-350.
20.05.2016Handheld single photon emission computed tomography (handheld SPECT) navigated video-assisted thoracoscopic surgery of computer tomography-guided radioactively marked pulmonary lesions
20.05.2016Interact Cardiovasc Thorac Surg 2016; 23:345-350
Müller Joachim, Putora Paul Martin, Schneider Tino, Zeisel C, Brutsche Martin, Bartz-Batliner Mira, Markus Alexander, Kick Jochen
Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study
Neumair P, Krähenbühl S, Baty F, Brutsche M, Früh M, Hitz F, Ess S, Warschkow R, Joos L, Jörger M (2016). Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study - Abstrakt 169P.
15.04.2016Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study
15.04.2016European Lung Cancer Conference
Neumair P, Krähenbühl S, Baty Florent, Brutsche Martin, Früh Martin, Hitz Felicitas, Ess S, Warschkow Rene, Joos L, Jörger Markus
61PD 24h-blood profile gene expression biomarkers of the response to targeted therapy in advanced non-squamous non-small cell lung cancer (NSCLC)
Baty F, Jörger M, Früh M, Brutsche M. 61PD 24h-blood profile gene expression biomarkers of the response to targeted therapy in advanced non-squamous non-small cell lung cancer (NSCLC). J Thorac Oncol 2016; 11:S81.
15.04.201661PD 24h-blood profile gene expression biomarkers of the response to targeted therapy in advanced non-squamous non-small cell lung cancer (NSCLC)
15.04.2016J Thorac Oncol 2016; 11:S81
Baty Florent, Jörger Markus, Früh Martin, Brutsche Martin
In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012
Pohle S, Baty F, Brutsche M. In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012. PloS one 2016; 11:e0151940.
17.03.2016In-Hospital Disease Burden of Sarcoidosis in Switzerland from 2002 to 2012
17.03.2016PloS one 2016; 11:e0151940
Pohle Susanne, Baty Florent, Brutsche Martin